Estimating vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings in South Africa, 2015
- PMID: 27865064
- PMCID: PMC5304569
- DOI: 10.1111/irv.12436
Estimating vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings in South Africa, 2015
Abstract
Trivalent seasonal influenza vaccine effectiveness during the 2015 season in South Africa was assessed using a test-negative case control study design. Influenza A(H1N1)pdm09 was the dominant circulating strain. Overall influenza vaccine coverage was 3.2% (29/899). The vaccine effectiveness estimate, against any influenza virus infection, adjusted for age, underlying conditions and timing within season was 46.2% (95% CI: -23.5 to 76.5), and 53.6% (95% CI: -62.6 to 80.3) against influenza A(H1N1)pdm09.
Keywords: effectiveness; influenza; vaccine.
© 2016 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.
Figures
References
-
- McAnerney JM, Cohen C, Moyes J, et al. Twenty‐five years of outpatient influenza surveillance in South Africa, 1984‐2008. J Infect Dis. 2012;206(Suppl 1):S153–S158. - PubMed
-
- Walaza S, Cohen C. Recommendations pertaining to the use of influenza vaccines and influenza antiviral drugs: Influenza 2015. SAMJ. 2015;105:90–91. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
